AI for Open Science: A Multi-Agent Perspective for Ethically Translating Data to Knowledge

AI for Science (AI4Science), particularly in the form of self-driving labs, has the potential to sideline human involvement and hinder scientific discovery within the broader community. While prior research has focused on ensuring the responsible deployment of AI applications, enhancing security, and ensuring interpretability, we also propose that promoting openness in AI4Science discoveries should be carefully considered. In this paper, we introduce the concept of AI for Open Science (AI4OS) as a multi-agent extension of AI4Science with the core principle of maximizing open knowledge translation throughout the scientific enterprise rather than a single organizational unit. We use the established principles of Knowledge Discovery and Data Mining (KDD) to formalize a language around AI4OS. We then discuss three principle stages of knowledge translation embedded in AI4Science systems and detail specific points where openness can be applied to yield an AI4OS alternative. Lastly, we formulate a theoretical metric to assess AI4OS with a supporting ethical argument highlighting its importance. Our goal is that by drawing attention to AI4OS we can ensure the natural consequence of AI4Science (e.g., self-driving labs) is a benefit not only for its developers but for society as a whole.Comment: NeurIPS AI For Science Workshop 2023. 11 pages, 2 figure

Learning the Finer Things: Bayesian Structure Learning at the Instantiation Level

Successful machine learning methods require a trade-off between memorization and generalization. Too much memorization and the model cannot generalize to unobserved examples. Too much over-generalization and we risk under-fitting the data. While we commonly measure their performance through cross validation and accuracy metrics, how should these algorithms cope in domains that are extremely under-determined where accuracy is always unsatisfactory? We present a novel probabilistic graphical model structure learning approach that can learn, generalize and explain in these elusive domains by operating at the random variable instantiation level. Using Minimum Description Length (MDL) analysis, we propose a new decomposition of the learning problem over all training exemplars, fusing together minimal entropy inferences to construct a final knowledge base. By leveraging Bayesian Knowledge Bases (BKBs), a framework that operates at the instantiation level and inherently subsumes Bayesian Networks (BNs), we develop both a theoretical MDL score and associated structure learning algorithm that demonstrates significant improvements over learned BNs on 40 benchmark datasets. Further, our algorithm incorporates recent off-the-shelf DAG learning techniques enabling tractable results even on large problems. We then demonstrate the utility of our approach in a significantly under-determined domain by learning gene regulatory networks on breast cancer gene mutational data available from The Cancer Genome Atlas (TCGA)

Progress toward a universal biomedical data translator

Clinical, biomedical, and translational science has reached an inflection point in the breadth and diversity of available data and the potential impact of such data to improve human health and well-being. However, the data are often siloed, disorganized, and not broadly accessible due to discipline-specific differences in terminology and representation. To address these challenges, the Biomedical Data Translator Consortium has developed and tested a pilot knowledge graph-based "Translator" system capable of integrating existing biomedical data sets and "translating" those data into insights intended to augment human reasoning and accelerate translational science. Having demonstrated feasibility of the Translator system, the Translator program has since moved into development, and the Translator Consortium has made significant progress in the research, design, and implementation of an operational system. Herein, we describe the current system's architecture, performance, and quality of results. We apply Translator to several real-world use cases developed in collaboration with subject-matter experts. Finally, we discuss the scientific and technical features of Translator and compare those features to other state-of-the-art, biomedical graph-based question-answering systems